In 2023, FDA approved one CRISPR/Cas9-based gene therapy to treat sickle cell disease, which marks a significant milestone in the translation of genome editing technologies into clinical therapeutics.

A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability that could lead to new therapies and bring the world closer to a ...

Denali National Park and Preserve opened the Denali Park Road to private vehicle traffic last week, a policy that will remain in place until the middle of next month. The road is scheduled to remain ...

Alaskans will begin receiving $1,000 Permanent Fund dividend payments next month, the Department of Revenue said Friday. The state will begin distributing dividends to eligible Alaskans on Oct. 2. A ...

A California outfit has used artificial intelligence to design viral genomes before they were then built and tested in a laboratory. Following this, bacteria was then successfully infected with a ...

IFLScience needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time.

Researchers at the German Center for Infection Research (DZIF) at Heidelberg University Hospital have decoded a previously unknown mechanism by which HIV-1 selects its integration targets in the human ...